Detection of endogenous tissue factor levels in plasma using the calibrated automated thrombogram assay

Thrombosis Research

Volumn 125, Issue 1, 2010, Pages 90-96

  Ollivier, Veronique ^a   Wang, Jianguo ^b   Manly, David ^b   Machlus, Kellie R ^b   Wolberg, Alisa S ^b   Jandrot Perrus, Martine ^a   Mackman, Nigel ^b  

^a INSERM   (France)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Plasma; Platelets; Thrombin; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 7; CITRIC ACID; LIPOPOLYSACCHARIDE; THROMBIN; THROMBOPLASTIN;

ARTICLE; AUTOANALYZER; BLOOD CLOTTING; CALCIFICATION; CALIBRATED AUTOMATED THROMBOGRAM; CONTROLLED STUDY; HUMAN; INCUBATION TEMPERATURE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE FREE PLASMA; THROMBOCYTE RICH PLASMA;

AUTOMATION; BIOLOGICAL ASSAY; CALIBRATION; HUMANS; PLASMA; PLATELET COUNT; PLATELET-RICH PLASMA; THROMBIN; THROMBOPLASTIN; TIME FACTORS;

EID: 76649083596     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.03.003     Document Type: Article

References (50)

1. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol 24 6 (2004) 1015-1022
2. Edgington T.S., Mackman N., and Brand K. The structural biology of expression and function of tissue factor. Thromb Haemost 66 (1991) 67-79
3. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Hematol 29 (1992) 170-176
4. Drake T.A., Morrissey J.H., and Edgington T.S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134 (1989) 1087-1097
5. Franco R.F., de Jonge E., Dekkers P.E.P., et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 96 (2000) 554-559
6. Morrissey J.H., and Drake T.A. Procoagulant response of the endothelium and monocytes. In: Schlag G., and Redl H. (Eds). Pathophysiology of shock, sepsis and organ failure (1993), Springer-Verlag, Berlin, New York 564-574
7. Osterud B., and Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavorable prognosis. Thromb Haemost 49 (1983) 5-7
8. Almdahl S.M., and Osterud B. Experimental gram-negative septicemia: Thromboplastin generation in mononuclear phagocytes from different anatomical sites. Thromb Res 47 (1987) 37-46
9. Gregory S.A., Morrissey J.H., and Edgington T.S. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9 (1989) 2752-2755
10. Osterud B., and Bjorklid E. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. Scand J Haematol 29 (1982) 175-184
11. Brand K., Fowler B.J., and Edgington T.S. Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol 11 (1991) 4732-4738
12. Mackman N., Brand K., and Edgington T.S. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J Exp Med 174 (1991) 1517-1526
13. Morel O., Toti F., Hugel B., et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 26 12 (2006) 2594-2604
14. Nieuwland R., Berckmans R.J., Rotteveel-Eijkman R.C., et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 96 (1997) 3534-3541
15. Diamant M., Nieuwland R., and Pablo R.F. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 106 19 (2002) 2442-2447
16. Aras O., Shet A., Bach R.R., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103 (2004) 4545-4553
17. Shet A.S., Aras O., Gupta K., et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 102 7 (2003) 2678-2683
18. Hron G., Kollars M., Weber H., et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97 1 (2007) 119-123
19. Tesselaar M.E., Romijn F.P., and Van Der Linden I.K. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5 3 (Mar 2007) 520-527
20. Biro E., Sturk-Maquelin K.N., Vogel G.M., et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 1 12 (2003) 2561-2568
21. Mallat Z., Hugel B., and Ohan J. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation 99 3 (1999) 348-353
22. Sommeijer D.W., Hansen H.R., van Oerle R., et al. Sobuble tissue factor is a candidate marker for progression of microvascular disease in patient with Type 2 diabetes. J Thromb Haemost 4 3 (2006) 574-580
23. Langer F., Chun F.K., Amerkhosravi A., et al. Plasma tissue factor antigen in localized prostate cancer: distribution,clinical significance and correlation with haemostatic activation markers. Thromb Haemost 97 3 (2007) 464-470
24. Misumi K., Ogawa H., Yasue H., et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 81 (1998) 22-26
25. Soejima H., Ogawa H., Yasue H., et al. Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris. Thromb Haemost 93 (1999) 17-25
26. Soejima H., Ogawa H., Yasue H., et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 99 (1999) 2908-2913
27. Shah M.D., Bergeron A.L., and Dong J.F. Flow cytometric measurement of micropartilces: pitfalls and protocol modifications. Platelets 19 5 (2008) 365-372
28. Khorana A., Francis C.W., Menzies K.E., et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6 (2008) 1983-1985
29. Hemker H.C., Willems G.M., and Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 56 1 (1986) 9-17
30. Duchemin J., Pan-Petesch B., and Arnaud B. Influence of coagulation factors and tissue factor concentration on the thrombin generation test in plasma. Thromb Haemost 99 (2008) 767-773
31. Bidot L., Jy W., Bidot C., et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 6 (2008) 913-919
32. Dielis A.W., Castoldi E., Spronk H.M., et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 6 (2008) 125-131
33. Hemker H.C., Giesen P., Aldieri R., et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 32 5-6 (2002) 249-253
34. Gatt A., van Veen J.J., and Woolley A.M. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. Thromb Haemost 100 2 (2008) 350-355
35. Gerotziafas G.T., Depasse F., and Chakroun T. Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma. Blood Coagul Fibrinolysis 15 (2004) 149-156
36. Livnat T., Zivelin A., and Martinowitz O. Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI. J Thromb Haemost 4 1 (2006) 192-200
37. Koestenberger M., Cvirn G., Nagel B., et al. Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease. Thromb Res 122 (2008) 13-19
38. Collins P.W., Macchiavello L.I., Lewis S.J., et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. Br J Haematol 135 (2006) 220-227
39. ten Cate-Hoek A.J., Dielis A.W., and Spronk H.M. Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost 100 (2008) 240-245
40. Dargaud Y., Trzeciak M.C., and Bordet J.C. Use of calibrated automated thrombinography +/- thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 96 (2006) 562-567
41. Luddington R., and Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2 11 (2008) 1954-1959
42. Carson S.D., Ross S.E., and Bach R. An inhibitory monoclonal antibody against human tissue factor. Blood 70 (1987) 490-493
43. Del Conde I., Shrimpton C.N., and Thiagarajan P. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 5 (2005) 1604-1611
44. Zillmann A., Luther T., Muller I., et al. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochem Biophys Res Commun 281 2 (2001) 603-609
45. Butenas S., Bouchard B.A., and Brummel-Ziedins K.E. Tissue factor activity in whole blood. Blood 105 7 (2005) 2764-2770
46. Panes O., Matus V., and Saez C.G. Human platelets synthesize and express functional tissue factor. Blood 109 (2007) 5242-5250
47. Schwertz H., Tolley N.D., Foulks J.M., et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203 11 (2006) 2433-2440
48. Butenas S., Branda R.F., and van't Veer C. Platelets and phospholipids in tissue factor-initiated thrombin generation. Thromb Haemost 87 3 (2002) 551-554
49. van Veen J.J., Gatt A., and Cooper P. Corn trypsin inhibitor in fluorogenic thrombin-generation measurements is only necessary at low tissue factor concentrations and influences the relationship between factor VIII coagulant activity and thrombogram parameters. Blood Coagul Fibrinolysis 19 (2008) 183-189
50. Keularts I.M.L.W., Zivelin A., and Seligsohn U. The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thromb Haemost 85 (2001) 1060-1065